Inovio Pharmaceuticals, Inc. announced today that its SynCon DNA vaccine containing multiple malaria antigens delivered via its CELLECTRA electroporation device demonstrated strong and durable antibody and T-cell immune responses in small animals and non-human primates.
http://www.freshnews.com/news/833076/inovio-pharmaceuticals-malaria-dna-vaccine-demonstrates-robust-immune-responses-animal-
http://www.freshnews.com/news/833076/inovio-pharmaceuticals-malaria-dna-vaccine-demonstrates-robust-immune-responses-animal-
No comments:
Post a Comment